| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $12.96T | $13.02T | $11.54T | $9.92T | $9.00T |
| Cost of Revenue | $8.50T | $8.09T | $7.17T | $5.85T | $5.07T |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $11.54T | $11.82T | $10.36T | $8.74T | – |
| R&D | $734.58B | $742.77B | $735.70B | $618.37B | $525.17B |
| SG&A | $2.26T | $2.16T | $1.97T | $1.59T | $1.47T |
| Operating Income | $1.41T | $1.21T | $1.21T | $1.20T | $971.87B |
| Interest Expense | $72.46B | $65.77B | $58.95B | $104.14B | $12.19B |
| Tax Expense | $313.84B | $288.17B | $236.69B | $229.10B | $995.00M |
| Net Income | $1.16T | $980.49B | $943.62B | $888.41B | $1.17T |
| EPS (basic) | 188.7100 | 788.2900 | 758.3800 | 711.8400 | 952.2900 |
| EPS (diluted) | 187.9200 | 785.6800 | 754.9500 | 705.1600 | 936.9000 |
| Shares (diluted) | $6.08B | $1.24B | $1.24B | $1.25B | $1.25B |